LY9 Antikörper (AA 301-400) (Cy3)
Kurzübersicht für LY9 Antikörper (AA 301-400) (Cy3) (ABIN741603)
Target
Alle LY9 (CD229) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 301-400
-
Verwendungszweck
- CD229 Polyclonal Antibody, Cy3 Conjugated
-
Homologie
- Human,Mouse,Rat,Pig
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CD229
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- LY9 (CD229) (Lymphocyte Antigen 9 (CD229))
-
Andere Bezeichnung
- Cd229
-
Hintergrund
-
Synonyms: hly9, mLY9, CD229, SLAMF3, T-lymphocyte surface antigen Ly-9, Cell surface molecule Ly-9, Lymphocyte antigen 9, SLAM family member 3, Signaling lymphocytic activation molecule 3, LY9, CDABP0070
Background: May participate in adhesion reactions between T lymphocytes and accessory cells by homophilic interaction.
-
Gen-ID
- 4063
-
UniProt
- Q9HBG7
-
Pathways
- BCR Signaling
Target
-